Rituximab 500mg/50ml solution for infusion vials
NHS hospitals in England used £119,129,954 of indicative cost of Rituximab 500mg/50ml solution for infusion vials in the 12 months to April 2026, about 0.5% of all hospital medicines spend. That is up 3.2% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Rituximab 500mg/50ml solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Rituximab 500mg/50ml solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Cambridge Univ Hosp Nhs Foundation Trust | £4,083,723 |
| Barts Health Nhs Trust | £3,986,803 |
| Univ Hpl B/Ham Nhs Foundation Trust | £3,840,638 |
| Imperial College Healthcare Nhs Trust | £3,831,382 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £3,816,538 |
| University College London Foundation Tr | £3,398,387 |
| Leeds Teaching Hpls Nhs Trust | £3,096,103 |
| University Hpls Of Leicester Nhs Trust | £3,027,211 |
| Guy's & St Thomas' Nhs Foundation Trust | £2,729,111 |
| Manchester University Nhs Ft | £2,708,861 |
The primary-care picture
Rituximab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Rituximab medicine page.